Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
20:29:50 EDT Mon 29 Apr 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
News for U:SUPN from 2023-04-30 to 2024-04-29 - 23 items
News Releases
In The News
Other
CA
US
Date
Sym
Price
Type
Headline
2024-04-24 16:06
U
U:SUPN
News Release
200
Supernus Pharmaceuticals to Announce First Quarter 2024 Financial Results and Host Conference Call on May 8, 2024
2024-04-08 08:00
U
U:SUPN
News Release
200
Supernus Provides Regulatory Update for SPN-830
2024-03-06 16:31
U
U:SUPN
News Release
200
Supernus to Participate in Two Upcoming Investor Conferences
2024-02-28 16:30
U
U:SUPN
News Release
200
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
2024-02-27 16:06
U
U:SUPN
News Release
200
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
2024-02-13 16:05
U
U:SUPN
News Release
200
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on February 27, 2024
2024-02-05 08:31
U
U:SUPN
News Release
200
Supernus Wins Infringement and Validity Case on Trokendi XR ‚ ® against Torrent
2023-12-19 07:30
U
U:SUPN
News Release
200
Knight Therapeutics Enters into Exclusive License Agreement with Supernus Pharmaceuticals for Qelbree ‚ ® (viloxazine) in Canada
2023-11-08 16:06
U
U:SUPN
News Release
200
Supernus Announces Third Quarter 2023 Financial Results
2023-11-07 16:31
U
U:SUPN
News Release
200
Supernus to Participate in the Jefferies London Healthcare Conference
2023-11-02 07:00
U
U:SUPN
News Release
200
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
2023-10-25 16:16
U
U:SUPN
News Release
200
Supernus Pharmaceuticals to Announce Third Quarter 2023 Financial Results and Host Conference Call on November 8, 2023
2023-10-16 17:34
U
U:SUPN
News Release
200
Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree ‚ ® Journey
2023-10-09 16:45
U
U:SUPN
News Release
200
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
2023-09-27 16:16
U
U:SUPN
News Release
200
Supernus Pharmaceuticals Announces Webcast of R&D Day to be Held ‚ on October 18, 2023 in New York City
2023-09-09 20:01
U
U:SUPN
News Release
200
Supernus Announces New Qelbree ‚ ® Data Showing Improvement in ADHD Symptoms
2023-08-31 17:30
U
U:SUPN
News Release
200
Supernus to Participate in the Wells Fargo Healthcare Conference
2023-08-21 09:01
U
U:SUPN
News Release
200
Bethany L. Sensenig Joins Supernus ¢ € ™ Board of Directors
2023-08-08 16:17
U
U:SUPN
News Release
200
Supernus Announces Second Quarter 2023 Financial Results
2023-07-24 16:05
U
U:SUPN
News Release
200
Supernus Pharmaceuticals to Announce Second Quarter 2023 Financial Results and Host Conference Call on August 8, 2023
2023-05-31 16:16
U
U:SUPN
News Release
200
Supernus to Participate in the Jefferies Healthcare Conference
2023-05-09 16:06
U
U:SUPN
News Release
200
Supernus Announces First Quarter 2023 Financial Results
2023-05-02 16:06
U
U:SUPN
News Release
200
Supernus to Present at the Bank of America 2023 Health Care Conference